| Product NDC: | 66993-162 |
| Proprietary Name: | glimepiride |
| Non Proprietary Name: | glimepiride |
| Active Ingredient(s): | 1 mg/1 & nbsp; glimepiride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66993-162 |
| Labeler Name: | PRASCO LABORATORIES |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020496 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20090618 |
| Package NDC: | 66993-162-02 |
| Package Description: | 100 TABLET in 1 BOTTLE (66993-162-02) |
| NDC Code | 66993-162-02 |
| Proprietary Name | glimepiride |
| Package Description | 100 TABLET in 1 BOTTLE (66993-162-02) |
| Product NDC | 66993-162 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | glimepiride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090618 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | PRASCO LABORATORIES |
| Substance Name | GLIMEPIRIDE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |